Hanfei Qi
ORCID:0000-0002-0072-5752
发表论文 25 篇 · 总被引 325 次 · h-index 7
代表论文
- Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma (2024 · Nature Immunology · 被引 105)
- Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers (2024 · Journal of Clinical Oncology · 被引 54)
- Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial (2024 · Nature Communications · 被引 50)
- Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells (2024 · Science Advances · 被引 47)
- A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages (2025 · OncoImmunology · 被引 18)
- Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 18)